Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Lung Cancer treatment details. Chemotherapy. Kyoto Prefectural University of Medicine, Kyoto, Japan

Survival: 15.7 months
Toxicity Grade: 4
Treatments: Chemotherapy
Country: Japan
City/State/Province: Kyoto
Hospital: Kyoto Prefectural University of Medicine
Journal: Link
Date: 12/2009

This phase II study involved 42 patients with advanced non-small-cell lung cancer that had not received any prior treatment. The median age was 62 years (range 36-75) and 82% were male.

Patients received two chemotherapy agents, gemcitabine and cisplatin. These drugs prevent cancer cell growth.

The highest toxicity reported for this study was of grade 4, which was mostly neutropenia (27% of patients). Other reported toxicities included leucopenia (grades 1-4), anemia (grades 1-4), and nausea/vomiting (grades 1-3).

The median overall survival for this study was 15.7 months.

Correspondence: Dr. Yoshinobu Iwasaki; email:

E-mail to a Friend Email Physician More Information